Avecho Biotechnology Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVEFF research report →
Price Chart
About the company
Avecho Biotechnology Limited is an Australian-based firm specializing in the development, production, and sale of various products. Central to its operations is the proprietary and patented Targeted Penetration Matrix (TPM) drug delivery system, which the company leverages across the pharmaceutical, skincare, animal health, and nutrition industries. Its product portfolio includes TPM and Vital ET, which are incorporated into drug delivery systems and cosmetic formulations.
- CEO
- Paul Gavin
- IPO
- 2018
- Employees
- 15
- HQ
- Clayton, VIC, AU
Get TickerSpark's AI analysis on AVEFF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $17.39M
- P/E
- -13.57
- PEG
- 0.14
- P/S
- 59.31
- P/B
- 41.73
- EV/EBITDA
- -11.72
- Div Yield
- 0.00%
- Gross Margin
- 60.70%
- Op Margin
- -485.09%
- Net Margin
- -248.73%
- ROE
- -258.19%
- ROIC
- -64.50%
Latest fiscal year · YoY change
- Revenue
- $1.24M-4.4%
- Gross Profit
- $750.99K-9.9%
- Op Income
- $-6,001,941.4
- Net Income
- $-4,414,887-41.4%
- EPS
- $0.00+100.0%
- OCF Growth
- +127.8%
- FCF Growth
- +127.8%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.11
- RSI (14)
- 100
- Avg Volume
- 230.00K
No earnings-call transcripts are available for AVEFF yet.
- Free Float
- 82.3%
- Shares Outstanding
- 3.86B
- Float Shares
- 3.18B
Our AVEFF coverage
Recent articles, reports, and earnings notes.
No research on AVEFF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AVEFF report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.